Angiogenesis in Myelodysplastic Syndromes
Author Information
Author(s): Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci P F, Buffa R, Lambertenghi-Deliliers G, Pezzella F
Primary Institution: IRCCS Maggiore Hospital
Hypothesis
How does angiogenesis differ in myelodysplastic syndromes compared to other conditions?
Conclusion
The study found that microvessel density in myelodysplastic syndromes is higher than in controls and infectious diseases but lower than in acute myeloid leukaemia and myeloproliferative disorders.
Supporting Evidence
- MDS microvessel density was significantly higher than in controls and infectious disease patients.
- MDS microvessel density was lower than in acute myeloid leukaemia and myeloproliferative disorders.
- VEGF expression was found to be strong in megakaryocytes but less prominent in other cell populations.
Takeaway
This study looked at how blood vessel growth works in a type of blood disease and found that it is different compared to healthy people and other blood diseases.
Methodology
Bone marrow microvessel density was assessed by immunohistochemistry in biopsies from various patient groups.
Participant Demographics
The study included 14 controls, 5 infectious disease patients, 82 myelodysplastic syndromes patients, 15 acute myeloid leukaemia patients, and 14 myeloproliferative disorder patients.
Statistical Information
P-Value
0.008
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website